✦ LIBER ✦

Increasing the Dose of Busulfan Results in Lower Relapse Rates and Higher Non-Relapse Mortality in Patients With MDS/AML Undergoing Reduced Intensity Allogeneic Stem Cell Transplantation

✍ Scribed by Y.-B. Chen; L. Sun; H. Kim; E.P. Alyea; P. Armand; E.C. Attar; K.K. Ballen; C. Cutler; B.R. Dey; J. Koreth; S.L. McAfee; T.R. Spitzer; J.H. Antin; R.J. Soiffer; V.T. Ho

Book ID: 116281982
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 55 KB
Volume: 17
Category: Article
ISSN: 1083-8791
DOI: 10.1016/j.bbmt.2010.12.011

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Allogeneic stem-cell transplantation in

Allogeneic stem-cell transplantation in patients with AML and MDS using myeloablative versus reduced-intensity doses of intravenous busulfan (Busulfex): The role of dose intensity

✍ A. Shimoni; M. Yeshurun; I. Hardan; A. Avigdor; N. Shem-Tove; I. Ben-Bassat; A. 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 53 KB

Lower Dose of Antithymocyte Globulin (AT

Lower Dose of Antithymocyte Globulin (ATG) Decreases Infection Rate without Increasing Graft-Vs-Host Disease (GVHD) and Relapse in Patients Undergoing Reduced-Intensity (RIC) Allogeneic Hematopoeitic Stem Cell Transplant (HSCT)

✍ Salem, Galena; Ruppert, Amy S.; Elder, Patrick; Hofmeister, Craig C.; Benson, Do 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 121 KB

Comparison between two fludarabine-based

Comparison between two fludarabine-based reduced-intensity conditioning regimens before allogeneic hematopoietic stem-cell transplantation: fludarabine/melphalan is associated with higher incidence of acute graft-versus-host disease and non-relapse mortality and lower incidence of relapse than fludarabine/busulfan

✍ Shimoni, A; Hardan, I; Shem-Tov, N; Rand, A; Herscovici, C; Yerushalmi, R; Nagle 📂 Article 📅 2007 🏛 Nature Publishing Group 🌐 English ⚖ 162 KB

High Rates of Non-Relapse Mortality and

High Rates of Non-Relapse Mortality and Graft-Versus-Host Disease in Patient Undergoing Allogeneic Stem Cell Transplantation (ASCT) Following Non-Myeloablative (NMA) Conditioning With TLI/ATG

✍ A.S. Kanate; L. Chaudhary; A. Cumpston; S. Leadmon; P. Bunner; D. Bulian; L. Gib 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 60 KB

Reduced Intensity Conditioning (RIC) All

Reduced Intensity Conditioning (RIC) Allogeneic Stem Cell Transplantation (AlloSCT) In Children and Adolescent Recipients is Associated With Very Low Regimen Related and Non-Relapse Mortality (NRM): However, Chemonaive Patients Following Umbilical Cord Blood Transplant (UCBT) have a Higher Incidence of Primary Graft Failure (PGF)

✍ P. Satwani; B. Tallamy; Z. Jin; V. Kohl; J. Garvin; M. Bhatia; D. George; B. Bra 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 90 KB

229: Twice-Daily Intravenous (IV) Busulf

229: Twice-Daily Intravenous (IV) Busulfan (Bu) x 4 Days in Children Undergoing a Reduced-Intensity Conditioning (RIC) Regimen with Allogeneic Hematopoietic Stem Cell Transplantation (AlloHSCT) is Safe and Well-Tolerated but Results in Significantly Increased Bu Clearance (CL) and Decreased Area Under the Curve (AUC) and Half-Life (t1/2) When Compared to IV Bu Twice-Daily Dosing Pharmacokinetics (PK) in Adults

✍ I. Waxman; M. Bhatia; M. Milone; L.M. Shaw; L. Baldinger; O. Militano; J. Garvin 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 60 KB